Experts: Cannabis Could Help Cure Alzheimer's If Lawmakers Would Chill Out
According to brain experts, cannabis is a herbal medicine that has shown promise for treating the cause of both dementia and Alzheimer's. And although this might sound like good news, federal regulators keep blocking the path toward a cure. Despite evidence that suggests that the chemicals found in cannabis can help clear the brain of the buildup that leads to dementia and Alzheimer's disease, ongoing federal opposition to the natural drug makes the road to finding a cure both long and difficult. As the Independent reports, scientists at the California's renowned Salk Institute are expressing their concern over the unfounded legal hurdles that keep slowing down the researchers work toward an effective treatment for these terrible and fatal diseases, which afflict millions of Americans each year.
Last year, the research team published study results that indicated the active chemicals or cannabinoids that are found in cannabis, such as euphoria-inducing tetrahydrocannabinol (THC), can effectively help to relieve the amyloid protein buildup and the cell damage that is related to dementia using some of the brain's own protective measures. Unlike other methods which seek to remove the amyloid buildup from the outside of the brain cells, cannabis works with the brain's natural endocannabinoids, which helps to prevent cell death, and to help fight the buildup inside cells and resulting inflammation at an earlier stage in the disease. Given the current lack of safe, and effective Alzheimers treatments and the overall low cost and often the minimal side-effects that are caused by medicinal cannabis as a natural cure, the studies should be cause for celebration for the advocates and the caregivers for the millions of Americans who suffer from dementia. It should also be cause for celebration for the over five million whose condition later develops into Alzheimer's disease. Alzheimer's is the most common kind of dementia, a disease for which fatality rates have risen by over 70 percent since 2000.
According to leading author Professor David Schubert, these innovative results would seem a lot more promising if the researchers' next steps weren't already bound up by the federal regulations and red tape. It's an unexplored area because the researchers have been stopped by the DEA, because of the way the agency classifies marijuana. The result is that no are no clinical trials that have been held to test the use of marijuana-based drugs in the treatment of Alzheimer's or any other neurodegenerative diseases. This is not right that they have such a strong say over something that could be very useful for people around the world.
People are dying of this terrible disease, and there is nothing available to help them. And the thing about Marijuana is that it is not physically addictive, although it can be psychologically addictive just like sugar, salt and fat, none of which are classified as Schedule I drugs. In the state of California, anyone can legally go down to the corner store and buy marijuana. According to Schubert the pharmaceutical industry, with its healthy lobbying power in D.C., is likely the major force in creating the legal hurdles for researchers. The pharmaceutical companies want to stop the use of cannabis within the research community because it's a herbal medicine, so it can't be patented. The pharmaceutical companies can't make money on cannabis, so they are against it. For the full story you will want to take a look at the Forbes site. You will find this article on how cannabis can be used as a natural cure for Alzheimer's on the Forbes site. On the site, you will find news, natural cures, tech, celebrity, herb remedies, herbal medicines, health and so much more. **
Learn MORE at Forbes
To help with slow website load, we have put all photos for this article here: View photo gallery.